Publications by authors named "Laura Jiminez-Juan"
Article Synopsis
- SGLT2 inhibitors like empagliflozin can improve heart failure outcomes in type 2 diabetes, but how they work is still not well understood.
- A study involving 90 patients with coronary artery disease and type 2 diabetes assessed the effects of empagliflozin on left atrial (LA) volume and function over 6 months.
- The results showed no significant changes in LA volume or function between the empagliflozin group and the placebo group, indicating that the drug may not impact these specific heart aspects.
Since the advent of multidetecter computed tomography (CT), radiologist sensitivity in detection of traumatic bowel and mesenteric abnormalities has significantly improved. Although several CT signs have been described to identify intestinal injury, accurate interpretation of these findings can remain challenging. Early detection of bowel and mesenteric injury is important as it alters patient management, disposition, and follow-up.
View Article and Find Full Text PDF